EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma

Fernanda Monedeiro, Denise Schimek, Eva-Maria Prugger, Thomas Altendorfer-Kroath, Elmar Zügner, Christoph Magnes

Analytica Chimica Acta · 2025

DOI: 10.1016/j.aca.2025.344183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025. Verfasst von Fernanda Monedeiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: HEALTH-Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft mbH, 8010, Graz, Austria. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Brain Neoplasms, Metabolomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Universität Graz, Karl-Franzens-Universität Graz, Republic of Austria Federal Ministry for Climate Action Environment Energy Mobility Innovation and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Glioblastoma exhibits a very poor prognosis and profound metabolic alterations associated to its aggressiveness. Examining tumor metabolic states is crucial for identifying potential therapeutic targets, enabling personalized medicine applications. However, direct access to the functional glioblastoma tumor microenvironment (TME) in vivo is highly challenging, particularly due to the tumor location and risk of blood-brain-barrier disruption. Here, we developed a novel research platform combining the innovative sampling technology cerebral open flow microperfusion (cOFM) and HILIC-HRMS-based metabolomics to comprehensively characterize the local metabolic phenotype of human glioblastoma in xenograft animal model. RESULTS: Interstitial fluid (ISF) collected directly from the functional inner TME without trauma generation using cOFM, plasma (PL) and cerebrospinal fluid (CSF) were analyzed. The proposed method enabled consistent measurements, detecting nearly 400 metabolites with adequate analytical quality in the study samples, of which 281 were found in brain ISF. ISF presented the highest number of discriminant metabolites, with over 30 % of the metabolome found to be altered in tumors compared to controls (p < 0.05). Fewer significant metabolic changes were assessed in CSF. Correlation analysis of ISF and PL indicated distinct metabolic fluxes through lipid metabolism in these two compartments. Pathway enrichment analysis indicated significant alterations in pathways related to mechanisms contributing to glioblastoma progression. Evaluation of ISF samples revealed that glioblastoma metabolic reprogramming may involve altered activity of ABC transporters, fatty acid oxidation, enhanced metabolism of central carbon, arginine, proline, and amino acid derivatives engaged in redox homeostasis. Evaluation of PL samples indicated a pronounced contribution of systemic lipid-mediated signaling. SIGNIFICANCE: ISF presented metabolic features and pathway activities from functional unaffected tumor, portraying metabolic traits of human glioblastoma tissue and corroborating the translational potential of this method. The novel cOFM-HILIC-HRMS research platform for in vivo/in situ monitoring of TME in glioblastoma can offer a promising and standardized tool for neuro-oncological research in the field of drug resistance and therapy development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaTumor MicroenvironmentBrain NeoplasmsMetabolomicsHumansAnimalsMiceExtracellular FluidMass SpectrometryMale

Stichwörter der Autor:innen

Cancer metabolismGlioblastomaHILIC-HRMSMetabolomicsXenograftcOFM

Autor:innen und Institutionen

  • HEALTH-Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft mbH, 8010, Graz, Austria.
  • HEALTH-Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft mbH, 8010, Graz, Austria. Electronic address: Denise.Schimek@joanneum.at.

Förderung

  • Medizinische Universität Graz
  • Karl-Franzens-Universität Graz
  • Republic of Austria Federal Ministry for Climate Action Environment Energy Mobility Innovation and Technology

Zitieren

APA

Monedeiro, F., Schimek, D., Prugger, E. M., Altendorfer-Kroath, T., Zügner, E., & Magnes, C. (2025). Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344183

Vancouver

Monedeiro F, Schimek D, Prugger EM, Altendorfer-Kroath T, Zügner E, Magnes C. Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma. Analytica Chimica Acta. 2025. doi:10.1016/j.aca.2025.344183

BibTeX
@article{Monedeiro2025,
  author = {Monedeiro, Fernanda and Schimek, Denise and Prugger, Eva-Maria and Altendorfer-Kroath, Thomas and Zügner, Elmar and Magnes, Christoph},
  title = {Cerebral open flow microperfusion (cOFM)-HILIC-HRMS platform for in vivo and in situ monitoring of tumor microenvironment in glioblastoma},
  journal = {Analytica Chimica Acta},
  year = {2025},
  doi = {10.1016/j.aca.2025.344183}
}
Kostenlos starten →